Romiplostim - Latest Advances

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Journal: Cureus

Published: October 15, 2025

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

Journal: Expert review of hematology

Published: September 29, 2025

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 09, 2025

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Journal: Cureus

Published: August 25, 2025

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Journal: The Journal of the Association of Physicians of India

Published: August 21, 2025

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Journal: Haematologica

Published: August 13, 2025

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Journal: BMJ open

Published: August 10, 2025

A new era in the treatment of aplastic anemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2025

Successful Treatment with Romiplostim After Eltrombopag-Induced Liver Injury in Immune Thrombocytopenic Purpura.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 28, 2025

Case Report: Life-threatening cisplatin-induced myelosuppression in pediatric osteosarcoma: molecular mechanisms, pharmacogenomic profiling, and targeted clinical management.

Journal: Frontiers in pharmacology

Published: July 17, 2025

Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment.

Journal: Current oncology (Toronto, Ont.)

Published: July 03, 2025

Impact of Thrombopoietin Receptor Agonists on Platelet Transfusion Requirements in Myelodysplastic Syndromes: An Updated Systematic Review and Meta-Analysis.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 01, 2025

Filters

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

A new era in the treatment of aplastic anemia

A new era in the treatment of aplastic anemia

Successful Treatment with Romiplostim After Eltrombopag-Induced Liver Injury in Immune Thrombocytopenic Purpura.

Successful Treatment with Romiplostim After Eltrombopag-Induced Liver Injury in Immune Thrombocytopenic Purpura.

Case Report: Life-threatening cisplatin-induced myelosuppression in pediatric osteosarcoma: molecular mechanisms, pharmacogenomic profiling, and targeted clinical management.

Case Report: Life-threatening cisplatin-induced myelosuppression in pediatric osteosarcoma: molecular mechanisms, pharmacogenomic profiling, and targeted clinical management.

Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment.

Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment.

Impact of Thrombopoietin Receptor Agonists on Platelet Transfusion Requirements in Myelodysplastic Syndromes: An Updated Systematic Review and Meta-Analysis.

Impact of Thrombopoietin Receptor Agonists on Platelet Transfusion Requirements in Myelodysplastic Syndromes: An Updated Systematic Review and Meta-Analysis.